Beta Bionics, Inc. 10-Q filing
Filed 2026-04-21 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-166843
- Form type
- 10-Q
- CIK
- 0001674632
- Primary document
- https://www.sec.gov/Archives/edgar/data/1674632/000119312526166843/bbnx-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beta Bionics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $27.6M | - | - |
| Cost Of Revenue | $11.2M | - | - |
| Gross Profit | $16.4M | - | - |
| Operating Income | $-24.3M | - | - |
| Net Income | $-21.9M | - | - |
| Eps Basic | -0.49 | - | - |
| Eps Diluted | -0.49 | - | - |
| Cash And Equivalents | $30.2M | - | - |
| Total Assets | $304.4M | - | - |
| Total Liabilities | $33.2M | - | - |
| Shareholders Equity | $271.2M | - | - |
| Operating Cash Flow | $-23.8M | - | - |
| Capital Expenditures | $1.4M | - | - |